Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.15 USD | +5.83% | +4.19% | -15.45% |
05-08 | Transcript : Arcus Biosciences, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
05-08 | Earnings Flash (RCUS) ARCUS BIOSCIENCES Posts Q1 Revenue $145M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.45% | 1.47B | |
+23.37% | 47.02B | |
+48.83% | 41.86B | |
-0.94% | 41.76B | |
-5.86% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- RCUS Stock
- News Arcus Biosciences, Inc.
- Morgan Stanley Cuts Price Target on Arcus Biosciences to $35 From $38, Maintains Overweight Rating